5.76

4.00% -0.24

Kura Oncology Inc (KURA)

Overview News Price History Option Chain Financials Discussions Forecast

Kura Oncology Inc stock is traded at $5.76, with a volume of 742.24K. It is down -4.00% in the last 24 hours and down -3.52% over the past month. Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathways.

Previous Close:

$6.00

Open:

$6.02

24h Volume:

742.24K

Relative Volume:

0.57

Market Cap:

$560.14M

Revenue:

Net Income/Loss:

$-168.09M

P/E Ratio:

-2.6544

EPS:

-2.17

Net Cash Flow:

$-138.01M

1W Performance:

-10.97%

1M Performance:

-3.52%

6M Performance:

-67.42%

1Y Performance:

-72.27%

1-Day Range:

$5.76

$6.12

1-Week Range:

$5.48

$6.76

52-Week Range:

$5.41

$23.48

Kura Oncology Inc Stock (KURA) Company Profile

Name

Kura Oncology Inc

Sector

Healthcare (1153)

Industry

Biotechnology (676)

Phone

(858) 500-8800

Address

12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO, CA

Employee

192

Twitter

@kuraoncology

Next Earnings Date

2025-02-21

Latest SEC Filings

KURA's Discussions on Twitter

Compare KURA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
KURA Kura Oncology Inc	5.76	560.14M	0	-168.09M	-138.01M	-2.17
VRTX Vertex Pharmaceuticals Inc	424.99	128.84B	11.10B	-988.90M	-1.26B	-3.92
REGN Regeneron Pharmaceuticals Inc	527.78	65.38B	14.09B	4.50B	2.96B	39.28
ARGX Argen X Se Adr	549.65	39.67B	2.19B	833.04M	-1.28B	12.71
ALNY Alnylam Pharmaceuticals Inc	251.15	33.82B	2.35B	-269.70M	-75.39M	-2.09
ONC Beigene Ltd Adr	231.99	27.60B	3.81B	-644.79M	-669.77M	-6.24

Kura Oncology Inc Stock (KURA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-06-25	Downgrade	BTIG Research	Buy → Neutral
Oct-24-24	Initiated	UBS	Buy
Oct-14-24	Downgrade	Stifel	Buy → Hold
Dec-22-23	Initiated	Mizuho	Buy
Aug-11-23	Initiated	BofA Securities	Buy
Jul-27-23	Initiated	Scotiabank	Sector Perform
May-17-23	Initiated	BTIG Research	Buy
Jan-31-23	Initiated	Stifel	Buy
Jul-12-22	Initiated	Cantor Fitzgerald	Overweight
Feb-15-22	Initiated	Jefferies	Buy
May-05-21	Resumed	Credit Suisse	Outperform
Apr-26-21	Resumed	Credit Suisse	Outperform
Dec-07-20	Reiterated	H.C. Wainwright	Buy
Dec-03-20	Initiated	Stifel	Buy
Nov-05-20	Downgrade	Piper Sandler	Overweight → Neutral
Jul-07-20	Initiated	Credit Suisse	Outperform
May-05-20	Initiated	Barclays	Overweight
Jul-18-19	Initiated	Deutsche Bank	Buy
Nov-09-18	Initiated	Piper Jaffray	Overweight
Aug-01-18	Initiated	H.C. Wainwright	Buy
Oct-13-16	Resumed	Leerink Partners	Outperform
Jan-22-16	Initiated	JMP Securities	Mkt Outperform
Dec-30-15	Initiated	Oppenheimer	Outperform
Dec-16-15	Initiated	Citigroup	Buy

View All

Kura Oncology Inc Stock (KURA) Latest News

03:22 AM

Dimensional Fund Advisors LP Buys 372,196 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

03:22 AM

May 07, 2025

Analysts Just Shipped A Captivating Upgrade To Their Kura Oncology, Inc. (NASDAQ:KURA) Estimates - simplywall.st

May 07, 2025

Wells Fargo & Company MN Acquires 11,427 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

May 07, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlook By Investing.com - Investing.com Canada

May 07, 2025

MetLife Investment Management LLC Purchases 2,776 Shares of Kura Oncology, Inc. (NASDAQ:KURA) - Defense World

May 07, 2025

May 06, 2025

Kura Oncology’s SWOT analysis: ziftomenib’s potential drives stock outlook - Investing.com Australia

May 06, 2025

Kura Oncology to Participate in Bank of America Securities Healt - GuruFocus

May 06, 2025

KURA Stock Set for Competitive Landscape in Menin Inhibitor Mark - GuruFocus

May 06, 2025

Kura Oncology to Participate in Bank of America Securities Healthcare Conference - The Manila Times

May 06, 2025

Kura Oncology CEO Sets Stage for Major Updates at BofA Healthcare Conference Next Week - Stock Titan

May 06, 2025

May 05, 2025

Kura Oncology (NASDAQ:KURA) Cut to Hold at StockNews.com - Defense World

May 05, 2025

FY2026 EPS Estimates for Kura Oncology Increased by Analyst - Defense World

May 05, 2025

Barclays Cuts Kura Oncology (NASDAQ:KURA) Price Target to $11.00 - Defense World

May 05, 2025

May 04, 2025

Earnings Update: Kura Oncology, Inc. (NASDAQ:KURA) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st

May 04, 2025

Kura Oncology, Inc. (NASDAQ:KURA) Given Average Rating of “Moderate Buy” by Analysts - Defense World

May 04, 2025

May 03, 2025

Kura Oncology (NASDAQ:KURA) Shares Gap Down Following Weak Earnings - Defense World

May 03, 2025

May 02, 2025